HC Wainwright reiterated their buy rating on shares of Precision BioSciences (NASDAQ:DTIL – Get Rating) in a research report report published on Wednesday morning, Benzinga reports. HC Wainwright currently has a $17.00 price objective on the stock. HC Wainwright also issued estimates for Precision BioSciences’ Q4 2023 earnings at ($0.21) EPS, FY2023 earnings at ($0.87) EPS, FY2024 earnings at ($0.60) EPS, FY2026 earnings at $0.37 EPS and FY2027 earnings at $0.73 EPS.
DTIL has been the topic of a number of other reports. BTIG Research dropped their price target on Precision BioSciences to $6.00 in a research note on Tuesday, November 15th. BMO Capital Markets downgraded Precision BioSciences from an outperform rating to a market perform rating and dropped their price target for the stock from $7.00 to $4.00 in a research note on Monday, March 13th.
Precision BioSciences Stock Performance
Shares of DTIL opened at $0.87 on Wednesday. The business’s fifty day simple moving average is $1.16 and its two-hundred day simple moving average is $1.29. The company has a current ratio of 3.34, a quick ratio of 3.34 and a debt-to-equity ratio of 0.37. Precision BioSciences has a 12 month low of $0.84 and a 12 month high of $3.64. The company has a market cap of $96.83 million, a price-to-earnings ratio of -0.62 and a beta of 1.45.
Hedge Funds Weigh In On Precision BioSciences
Precision BioSciences Company Profile
Precision BioSciences, Inc is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases.
- Get a free copy of the StockNews.com research report on Precision BioSciences (DTIL)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Precision BioSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision BioSciences and related companies with MarketBeat.com's FREE daily email newsletter.